There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Scientists from the University of Washington have uncovered an important clue about keeping your brain healthy as you age: ...

The 3 rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drug delivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative ...

Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million upfront for global rights to two preclinical antibodies.

In contrast, folks with the newly discovered gene variant had only small amounts of fibronectin within their blood-brain barrier. That means that certain toxins -- including amyloid plaques that ...

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Ultimately, Suvannevejh said anti-amyloid antibodies are a “viable approach” to Alzheimer’s, but that Leqembi, Kisunla and Aduhelm are “probably not” the most optimal treatments. The challenge, he ...

On a recent visit to Washington DC, Ho sat down with GEN Editorial Director Kevin Davies, PhD, to discuss Denali’s progress ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...